Ongoing market analysis
Digital Health Insights
Current funding analysis, market commentary, and evidence-led perspectives, supported by a searchable record of earlier research.
Showing 18 of 224 insights
The GLP-1 Adherence Gap: Why Digital Partnerships Matter More to Pharma in 2026, Even as Deal Volumes Fall
Pharma’s partnerships with digital health ventures fell 21% in the first nine months of 2026, yet deals with obesity care-delivery ventures hit a record nine, because GLP-1 drugs only pay off if patients stay on them.
Ten of the 15 Most Active Pharma Partners Are Now Asian Ventures: APAC Is Building Its Digital Health Ecosystem From Within
Pharma partnering with digital health ventures has shrunk sharply in North America and Europe. In Japan, South Korea, China and Hong Kong it has grown, creating a regional flywheel set to define APAC digital health in 2027.
Seven Things to Stop Funding Before Your 2027 Budget Is Signed
Early-stage digital health rounds fell 63% since 2022. Seven things to stop funding before your 2027 digital health budget is signed.
Build, Buy or Partner: How to Spend a 2027 Digital Health Budget
The AI label now carries a 16% funding discount and acquired ventures average 10.7 years old. How to choose between building, buying and partnering in 2027.
The Ten-Week Window: A Q4 Planning Guide for Your 2027 Digital Health Budget
Most 2027 innovation budgets are written in the next ten weeks. Part one of Galen Growth’s Q4 planning guide: the market you are budgeting into
Read-Only Is the Whole Story: OpenAI's Epic Integration and the Clinical Reasoning Layer, September 2026
OpenAI's Epic integration is read-only — no notes, no orders, no codes. Epic, Abridge and Ambience shipped chart reasoning first, and $1.32B backed them in 2025.SEO key phrase: OpenAI Epic integration
Pharma's Digital Health Partnerships: The Asset Investors Don't See
Pharma holds 1,707 Digital Health partnerships across 13 portfolios — a measurable asset investors ignore. Novartis converts 31% to evidence grade; Bayer 18%.
The Operating System Around the Drug: Patient Support Programmes in 2026
281 ventures, US$5.9bn raised, 628 pharma partnerships: patient support programmes are becoming treatment infrastructure. Galen Growth, 2026.
Why Hinge Health Paid $105 Million for a Company Worth Just $8 Million in Revenue
Hinge Health paid $105M for Cylinder Health, but the deal adds just $7–8M in 2026 revenue — Galen Growth's analysis of the platform-building logic behind it.
Digital Health Funding 2026: Ventures with Strong Clinical Evidence Raise 3.5x More
Ventures with strong clinical evidence raised 3.5x more in 2026 YTD ($112.9M vs $24.3M/round) — Galen Growth digital health funding analysis.
Digital Health Investment Trends in H1 2026: 5 New Rules of Healthcare Innovation Venture Capital
Deal volume fell 63% in H1 2026, yet capital held at $16.6B. Galen Growth's H1 2026 Key Trends analysis reveals the 5 new rules reshaping digital health VC.
H1 2026 Healthcare Trends: Health Systems Are Buying Infrastructure, Not Apps
Health-system partnerships with infrastructure ventures rose to 22.8% in H1 2026 from 18.8% in 2022, Galen Growth's H1 2026 data show.
The Return of the Strategic Buyer: M&A Captured 98% of Digital Health Exits in H1 2026
M&A captured 97.6% of digital health exits in H1 2026 as IPOs fell to one listing. Galen Growth's H1 2026 exit analysis, powered by HealthTech Alpha.
H1 2026 Digital Health Trends: Why Partnerships Matter More Than Funding
Partnerships fell 20% vs a 37% funding deal decline in H1 2026. Galen Growth’s definitive read on why partnerships now signal digital health demand.
Global funding held broadly steady at $22.6B — H1 2026 data shows capital concentrating in fewer, larger, more scrutinised bets.
Global digital health funding held steady at $22.6B in H1 2026, but deal count fell 38% to 608. Galen Growth's definitive analysis of the maturity era.
Digital Health Exits in 2026: M&A Dominance, Longer Hold Periods, and Strategic Consolidation
95% of 2025–2026 digital health exits were M&A. Galen Growth analysis of exit routes, hold periods, and capital concentration for 2026.
The Q3 Intelligence Window: Why Alpha Briefs Matter Before the Q4 Push
Q3 offers a 12-week window to turn healthcare innovation noise into Q4-ready decisions with Galen Growth Alpha Briefs.
The €5 billion question: is Europe finally building strategic capital — or still thinking too small?
Scaleup Europe Fund targets €5bn, but HealthTech Alpha data shows Europe’s real gap is Series C–E growth capital
Big Tech is no longer experimenting at the edges of healthcare. Microsoft, Amazon, Google, Apple, NVIDIA and Meta are becoming part of healthcare’s infrastructure, AI, data, consumer access and venture partnership layer.
Big Tech is becoming part of the operating system of modern healthcare. From AI and cloud infrastructure to wearables, pharmacy, clinical workflow and digital health partnerships, companies such as Microsoft, Amazon, Google, Apple and NVIDIA are reshaping how healthcare is delivered, analyzed and accessed.
The $2.1bn wager on machine-made medicine: why Isomorphic Labs may redraw the economics of drug discovery
Isomorphic Labs' $2.1B Series B signals a major shift in AI drug discovery. Explore what the funding means for pharma, investors, AI biology and the future of medicine.
The Investable Core: Why Investors Are Backing Health Management Solutions in 2026
Roche’s $1.05bn acquisition of PathAI raises new questions around AI infrastructure neutrality, companion diagnostics and vendor governance
Roche acquires PathAI: pharma partners face a vendor-risk problem
Roche’s $1.05bn acquisition of PathAI raises new questions around AI infrastructure neutrality, companion diagnostics and vendor governance
AI in U.S. Healthcare Operations: Why Health Management Solutions Became the New Infrastructure Layer
U.S. Health Management Solutions funding reached $4.5B in 2025, with 83% of Q1 2026 funding going to AI-powered ventures. See why healthcare operations, workflow automation, and clinical data infrastructure are becoming the new AI infrastructure layer.
The Execution Decade: Why Clinical Trials Are Pharma’s 2026 R&D Bottleneck
Digital health raised $25.7bn in venture equity in 2025, but Clinical Trials — the layer fixing pharma’s productivity problem — took just $350m. The misallocation to correct in 2026.
The Administration Problem: How $5.6B Rewired Health Management Solutions in 2025
Health Management Solutions captured $5.6B in 2025 venture funding — 83% to AI. Galen Growth's analysis of the global HMS reset.
Scale, Speed, and State Power: Asia Pacific’s Digital Health Funding Market in Q1 2026
Asia Pacific digital health funding hits $2.65B in strategic deals vs $244M VC in Q1 2026, revealing a bifurcated, infrastructure-driven market.
Proof, Precision, and Power: Europe’s Digital Health Funding Market in Q1 2026
Europe digital health funding hits $1.2B in Q1 2026 as late-stage funding, provider partnerships, and M&A signal market maturity.
The American Powerplay: U.S. Digital Health Funding in Q1 2026
U.S. digital health funding captured 76% of global funding in Q1 2026. Explore VC trends, AI dominance, partnerships, and exits shaping the market.
Global Digital Health Ecosystem Q1 2026 Performance Review
Explore Q1 2026 digital health trends: $7.1B funding, rising M&A, and the shift toward clinical, scalable solutions.
Digital health funding in Clinical Trials: Why Execution, Not Discovery, is Pharma’s Next Existential Bottleneck
Clinical trial execution, not discovery, is pharma’s real bottleneck as AI, DCTs, and workflow innovation reshape the market.
Next Generation Power Players: HealthTech 250 Reveals 50 Emerging Digital Health Startups in Top Clusters
Explore the 2026 HealthTech 250—top digital health startups across key clusters driving $29.7B in funding and evidence-backed innovation.
The Signal Beneath the Noise: What the 2026 HT250 Tells Investors About Where Digital Health Is Actually Heading
Explore what the 2026 HT250 reveals about digital health investment trends, AI adoption, clinical validation, and where investors should look across the US, Europe, and APAC.
Coming of Age in Basel: Digital Health Acts its Age at health.tech 2026
health.tech 2026 in Basel showed digital health entering its implementation era, from AI deployment and governance to prevention systems and digital clinical trials.
Beyond the Hype: Why the HealthTech 250 APAC Cohort Matters
The HealthTech 250 APAC cohort highlights 50 early-stage digital health startups across Asia Pacific backed by funding momentum, partnerships, and real ecosystem traction.
Rewiring Healthcare with the HealthTech 250 U.S. Cohort
Discover the 2026 HealthTech 250 U.S. cohort — 75 early-stage digital health startups transforming healthcare operations, oncology innovation, and therapeutic-specific care.
Beyond the Hype: The HealthTech 250 Europe 2026 Cohort Highlights the Digital Health Startups Driving Real Innovation
Explore the HealthTech 250 Europe 2026 cohort: 50 early-stage digital health startups leading in AI, oncology, diagnostics, and evidence-backed innovation.
Carbon Health: How a US$2.8bn Digital Health unicorn discovered clinics don’t scale like software
A $2.8bn digital health unicorn enters Chapter 11—revealing why clinics don’t scale like software and what investors should learn.
Vertical AI in Healthcare: Vertical AI Beats Horizontal in the Agentic AI Era — Why Specialist Intelligence Wins
In the agentic AI era, defensibility shifts from foundation models to vertical data moats. In healthcare, specialist Digital Health Intelligence platforms outperform horizontal systems by providing domain-specific taxonomy, entity resolution, auditability, and governance required for decision-grade enterprise deployment.
Digital health exits: fewer fireworks, firmer foundations
Digital health exits reached $13.9bn in 2025, marking a 10.6% year-on-year increase and signaling a shift from volatility to a more disciplined, M&A-driven baseline. Venture-to-venture acquisitions now dominate consolidation, while capital increasingly flows to infrastructure-heavy segments like research solutions and health management. As IPOs remain selective, 2026 is set to further entrench strategic, integration-led exits over valuation-driven outcomes.
The Galen Growth HealthTech 250, one year on: separating signal from noise in digital health ventures
One year after selection, the 2025 HealthTech 250 demonstrates exceptional resilience, raising $1.6B, securing 1,001 partnerships, and maintaining a 96% survival rate. In a selective capital market, evidence, workflow integration, and measurable ROI—not hype—are defining digital health’s real winners.
Shaping the Future of Digital Health: Galen Growth’s Conference Line-Up for 2026
See where to meet Galen Growth in 2026—from JPM to HLTH Europe and HLTH USA—and what evidence-led signals we track using HealthTech Alpha.
2025 Was the Year Europe Got Paid. 2026 Is the Year Europe Must Prove It Was Worth It.
Europe led global digital health funding growth in 2025, driven by U.S. capital. In 2026, exits not rounds will determine success.
Sword Health’s European Roots Fuel a Global Power Play
Sword Health’s $285M Kaia Health acquisition signals digital MSK consolidation, blending sensors, AI vision, and Germany’s DiGA moat.
U.S. Digital Health Funding 2025: The Year the Health System Took the Driver’s Seat
U.S. digital health funding hit $19.2B in 2025—but power shifted to health systems. Learn why workflow ROI, EHR integration, and provider adoption now define what scales.
Asia Pacific Digital Health 2025: Australia Leads, Women’s Health Surges, and a Cash Crunch Looms
APAC digital health funding rose 14% in 2025. Australia leads, Women’s Health surges, and a growth-stage cash crunch emerges.
Digital Health Funding 2025: the year capital stopped believing the hype
Digital health funding hit USD 28.8B in 2025—but concentrated into fewer winners. Europe grew fastest, and buyers demanded ROI, evidence, and interoperability.
Digital Health 2026: Ten Predictions as the Industry Shifts From Hype to Hardwiring
In 2026, digital health shifts from experimentation to infrastructure. Ten predictions on clinical-grade data, operational AI, interoperability, regulation, and capital.
Digital Health Funding in 2025: From Hype to Hard Results
In 2025, digital health funding reset around discipline, outcomes, and real-world impact—creating a stronger foundation for sustainable growth.
In Uncertain Times, Innovation Lights the Way: Year-End Reflections
A year-end reflection on how healthcare innovation, AI, and digital health matured in 2025 despite geopolitical and economic uncertainty.
The Twelve Days of Digital Health (2025 Edition)
This article provides a structured, evidence-led overview of digital health trends in 2025, covering pharma, payers, providers, regulators, and health technology vendors globally.
Who has the Golden Checkbook: Inside the 50 Core Investors Re-Wiring Global Digital Health (2025)
The HT50 Core Investors 2025 report reveals the 50 investors shaping global digital health—across stages, regions and themes. Drawing on HealthTech Alpha data, it shows how capital, evidence and partnerships are redefining who really moves the market.
From Vision to Global Impact: Galen Growth Turns 10
Celebrating 10 years of Galen Growth, the Singapore-born global leader in Digital Health Intelligence powering evidence-based decisions across healthcare.
Who is really winning pharma’s digital health innovation race in 2025?
Galen Growth’s 2025 Pharmaceutical Digital Health Innovation Index ranks the 25 most active global pharma companies on how effectively they embed digital health across strategy, execution and venture portfolios. The report reveals which firms are truly leading – from Proactive quadrant powerhouses like Novartis and AstraZeneca to R&D specialists and patient-first pioneers – using only independent, evidence-led data from HealthTech Alpha.
The Great Remote Patient Monitoring Reckoning: Why UnitedHealthcare’s Policy Change Demands a Systemic Digital Health Reset
UnitedHealthcare’s rollback of remote patient monitoring coverage is a pivotal market signal exposing the unsustainable economics of CPT-dependent RPM companies. Beyond the legal controversy, the move accelerates a structural shift toward integrated, outcome-driven digital health models. Startups must now prove defensible clinical and financial ROI, integrate deeply into care pathways, and partner strategically with payors and EHR platforms—or risk obsolescence.
TrumpRx Drug Price Mandate Disrupts Pharma’s Direct-to-Patient (DTP) Evolution: 3 Key Hypotheses
TrumpRx Drug Price Mandate Disrupts Pharma’s Direct-to-Patient (DTP) Evolution: 3 Key Hypotheses
Smart Trials, Swift Cures: How Regulators are Contributing to the Digital Transformation of Clinical Trials
Regulators are accelerating the digital transformation of clinical trials. The UK’s AI-driven approval reforms and the FDA’s digital health guidance signal a new era of faster, smarter, and safer research. As Galen Growth data show, AI now powers nearly all venture funding in this space — turning the clinical trial bottleneck into a breakthrough opportunity.
Clearing the Bottleneck: How Digital Innovation Is Re-Engineering Clinical Trials
Despite breakthroughs in AI-powered drug discovery, progress often stalls when treatments enter the clinical phase.
Europe Digital Health Funding in Q3 2025: Resilience Amid Rationalisation
Europe Digital Health Funding Q3 2025 reached $1.0B across 55 deals, showing resilience amid global slowdown. Discover key trends in AI, partnerships, and investor priorities.
APAC Digital Health Funding Q3 2025: Slower Growth, Stronger Signals
APAC digital health funding Q3 2025 reached $416M, marking a 20% QoQ decline but stronger deal quality and partnership momentum across the region.
US Digital Health Q3 2025: Caution, Consolidation, and a New Clinical AI Order
US digital health in Q3 2025 traded hype for hard evidence: fewer deals, larger checks, and AI moving from feature to infrastructure. Partnerships dipped but matured, exits remained active, and reimbursement alignment defined the winners.
Beyond Funding: Evidence and Partnerships Give DiMe Seal Ventures the Edge
DiMe Seal ventures outperform peers in digital health — stronger evidence, more partnerships, and capital efficiency backed by Galen Growth data.
HLTH USA 2025: Why Health Systems Are Driving the Digital Health Revolution
Discover why Health Systems lead digital health innovation at HLTH USA 2025. Explore partnership trends, AI adoption, and the startups reshaping healthcare.
Digital Health Q3 2025: Global Investment Cools, AI Heats, and Partnerships Redefine Growth in Digital Health
Digital Health in Q3 2025 saw USD 5.7 billion raised, driven by AI-first ventures and mega-deals, as the market leaned towards later-stage consolidation and strategic partnerships.
Who to Meet at HLTH USA 2025: Galen Growth’s Data-Led Playbook and Top 10 Series A Startups
Discover Galen Growth’s data-led playbook for HLTH USA 2025 — the premier U.S. digital health conference. Explore the top 10 Series A startups, partnership insights, and evidence-based strategies powered by HealthTech Alpha to plan your most effective networking and investment meetings.
Generative AI Will Redefine Market Research — How Corporates Can Turn Data into Decisions
Generative AI is transforming corporate market research from data gathering to decision enablement. Discover how Digital Health and strategy teams can leverage explainable AI and trusted data to deliver faster, evidence-based insights — powered by Galen Growth’s HealthTech Alpha.
Why GenAI Can’t Replace Human-Led, Domain-Deep Intelligence: The Galen Growth Perspective
While LLMs can parse documents and visualise trends, they fail at drawing contextual conclusions or building investment-grade forecasts — especially in complex sectors like healthcare.
Pharma’s Direct-to-Patient Pivot (2025): LillyDirect, PfizerForAll & NovoCare Models
Big Pharma is moving from DTC advertising to DTP infrastructure—brand-owned digital front doors combining telehealth, e-prescribing, and home delivery
How Generative AI Will Reshape Digital Health Startups – and What They Must Do to Adapt
65% of global Digital Health companies operate with a B2B business model or a hybrid, making them directly exposed to the disruptive impact of generative AI.
European Digital Health Bucks The Trend
The European Digital Health landscape is undergoing a significant transformation, evolving beyond the initial hype to a phase where tangible results and proven impact dictate investment.
HealthTech 250 Thriving Amid Adversity – Mid-2025 Trends & Outlook
This is Part 2 of our two-part series on the HealthTech 250 — Galen Growth’s annual list of the 250 most promising early-stage digital health companies in the world.
Generative AI in Healthcare: From Pilots to Proven Impact
Based on 52 interviews with enterprise stakeholders, 95% of generative AI pilots in Healthcare at companies are failing to deliver measurable financial impact.
Epic Joins the AI Scribe Race: Can Startups Still Win?
The entry of the electronic health record giant into the ambient scribe market marks a turning point—but does it spell the end for startups, or the beginning of a more innovative era?
HealthTech 250 Mid-Year 2025 Check-In: Weathering a Tumultuous Year
Galen Growth presents the definitive annual list of the 250 most promising early-stage digital health companies worldwide.
POV: “Make Health Tech Great Again” — Decoding the White House–CMS Announcement for Digital Health
The White House and Centers for Medicare & Medicaid Services announced a voluntary CMS Interoperability Framework, a commitment to create CMS-Aligned Networks, and a suite of upgrades to identity, directories, and data access in U.S. healthcare.
U.S. Digital Health Funding in Q2 2025: A Maturing Ecosystem with Healthcare Impact
U.S. digital health funding reached $7.5 billion in H1 2025—down 28% YoY, while AI-powered ventures made up 63% of total investment.
APAC Digital Health Funding in Q2 2025: AI-Driven Momentum in a Shifting Global Landscape
APAC digital health funding hit $1.2B in Q2 2025, led by AI, diagnostics, and women’s health. Explore key trends, exits, and mega deals across the region.
Proof Over Promise: H1 2025 Marks a Turning Point in Digital Health Funding
Digital Health funding hit $12.1B in H1 2025. Europe surged, AI-led deals rose, exits lagged—proof and outcomes now drive investor focus.
Digital Health Exits: Navigating 2025's Shifting Tides Towards Maturity
Explore Digital Health Exits in Q2 2025, as the sector shifts toward selective scale, clinical strength, and clear paths to profitability.
Q2 2025 Digital Health Pulse Check: Navigating Selective Growth and Evolving Liquidity
At the end of Q2 2025 digital health funding saw a total investment of $12.1B, across 615 deals. Here are the main drivers.
A Decade of Digital Health Innovation – Time to Break the Mould
AI is reshaping digital health. Discover how the ecosystem must evolve to fix bias, noise, and inefficiency in innovation and deal sourcing.
GenAI Mandates, Femtech & Digital Health Funding: The Trends from HLTH Europe 2025
Explore the top trends from HLTH Europe 2025, cautitious digital health funding, GenAI mandates, femtech boom and the evolution of the European digital health ecosystem.
Femtech’s Rise and Roadblocks: Digital Health Funding, Growth and Gaps
Femtech is evolving through digital health funding, sector growth, and gaps in care, innovation, and access across digital health ecosystem.
Health Systems as Innovators, Investors, and Implementers
Health Systems lead digital health innovation, investing in AI and forming strategic partnerships to transform healthcare delivery.
Q1 2025 Digital Health Funding Trends: Mega Deals, AI & European Growth Explored
Total Q1 2025 Digital Health funding reached a robust $6.3 billion, representing a modest increase of 2% year-on-year (YoY).
Navigating The Tariff Tangle: Unpacking the Impact on Digital Health
The Potential Impact of New Trade Tariffs from the United States and Market Volatility on Digital Health.
Consumer HealthTech: A Paradigm Shift in Healthcare
Discover how AI, wearables, and proactive care are fueling the Consumer HealthTech revolution—reshaping healthcare delivery, investment, and innovation.
Q1 2025 Digital Health Funding: AI, Mega Deals & Europe’s Breakout Quarter
Q1 2025 Digital Health funding reached $6.3 billion of invested capital. AI, mega deals, and Europe's rise power a resilient sector.
U.S. Digital Health 2025: Next-Generation Disruptors Highlighted in Galen Growth’s HealthTech 250
Galen Growth's 2025 HealthTech 250 highlights the most promising early-stage digital health startups across the globe, including 162 startups that were founded in the U.S.
Galen Growth’s HealthTech 250 Spotlights Emerging Leaders among APAC’s Healthtech Startups
Discover APAC's HealthTech startups revolutionizing healthcare in 2025 with innovation, funding trends, and emerging digital health leaders.
Europe’s Healthtech Startups on the Rise: Revealed in Galen Growth’s HealthTech 250
Europe's Healthtech Startups are spotlighted in the 2025 Healthtech 250 list, featuring the most promising early-stage HealthTech startups.
Mental Health’s Investment Resurgence: A Market Ripe for Innovation
The global mental health funding in digital health increased to $2.7 billion in 2024, a 38% rise in venture capital investment
The Pharma Race to Digital Supremacy: Why the Biopharma Sector is Banking on Digital Health Innovation
The top 25 biopharma companies account for 42% of global digital health partnerships, signalling a diffusion of innovation across the industry.
AI and TechBio Funding Lead the Charge: 2024 Digital Health Funding Resurgence
Digital health funding rebounded to $25.1B in 2024, led by AI & TechBio. Europe surged 27%, the US led with $17.2B, partnerships hit record highs.
Shaping the Future of Digital Health: Galen Growth's Conference Line-Up for 2025
Discover the top digital health conferences in 2025 and explore key trends shaping the future of digital health!
DeepSeek’s Low-Cost AI Training: Transforming AI in Digital Health and Global HealthTech
Explore how AI in Digital Health and DeepSeek's Low-cost training are revolutionizing AI, reducing costs, and driving innovation in global healthcare.
Galen Growth at WEF25: AI in Healthcare and Key Takeaways
Explore the transformative power of AI in healthcare, from diagnostics to drug discovery, and discover its future impact discussed at WEF25.
2024 Europe Digital Health Funding Propelled to Record Highs by Mega Deals and AI
Discover how 2024 Europe digital health funding reached record highs, driven by mega deals and advancements in AI, reshaping the healthcare innovation landscape.
U.S. Digital Health Funding in 2024 Breaks the Downward Trend
Explore key insights into 2024 U.S. digital health funding trends, venture investments, and partnerships shaping healthcare innovation.
2024 Digital Health Funding in Asia Pacific: A Snapshot
Explore the 2024 digital health funding landscape in the Asia Pacific region. Discover key investment areas, geographic distribution, and insights for investors and healthcare professionals. Galen Growth.
What’s Next in Digital Health? 10 Predictions for 2025 That Will Shape the Industry
Explore 10 Digital Health Predictions for 2025: AI, virtual care, obesity, platforms, and healthcare innovation trends.
Key Trends that Shaped Digital Health Innovation in 2024: A Galen Growth Analysis
Explore 2024 key trends, including digital health Funding analysis, AI-powered solutions, and M&A insights, driving innovation and growth in healthtech.
High Cost of Capital and Funding Drought: Are Investors Making Money in Digital Health?
Return on Invested Capital in Digital Health. Between 2019 and 2024, the digital health ecosystem witnessed a 5-year compound annual growth rate of approximately 8%.
Digital Health: a new front line in the fight against Cardiovascular Diseases
Explore the 2024 Galen Growth report: Advancing Cardiovascular Health: The Impact of Digital Health Innovation, focusing on digital health innovations, AI, mobile apps, and the future of cardiovascular care. Learn about the investment trends and regional insights shaping the digital health ecosystem.
The Medical Device Industry’s Digital Shift: Unlocking Digital Health Innovation
The medical device industry increasingly embraces AI and digital health innovation, though it has historically lagged behind other healthcare sectors.
Europe Digital Health Funding Soars 19% YoY as AI Ventures Thrive and Partnerships Surge in Q3 2024
Explore how Europea digital health funding soars in Q3 2024, with insights into rising investments, partnership dynamics, AI’s impact on healthcare, and therapeutic breakthroughs.
Q3 2024 Digital Health Funding: Global Ecosystem poised to outperform funding deployed in 2023
Global digital health funding surges in Q3 2024, reaching $20.1B year-to-date. Growth-stage investments dominate as AI-driven solutions gain traction.
Clinical Strength in Digital Health Innovation – Key Insights from the 2024 Report
Partnerships are crucial for driving clinical proof in digital health innovation. Learn how collaborations accelerate validation and fuel the growth of health tech ventures.
The Power of Partnerships: How Collaboration Drives Clinical Evidence in Digital Health
Discover the latest insights in digital health evidence. Explore how partnerships, funding, and clinical trials impact the growth and success of digital health ventures. Learn about the key trends and challenges shaping the future of healthcare innovation.
The Uncertain Future of Digital Health in Europe: Innovations Flourish Amid Funding Challenges
An in-depth analysis of the digital health landscape in Europe during the first half of 2024, exploring key investment trends, strategic partnerships, and the role of AI-driven innovations. Learn about the challenges and opportunities digital health ventures face and the critical importance of sustainable business models.
Mega Deals in Digital Health: Is Digital Health's Future Bigger Than Ever?
Explore the surge of digital health mega deals in H1 2024, with 26 investments totaling $4.9B, driven by AI, telemedicine & personalized medicine advancements. Key sectors include therapeutics, diagnostics & health management.
India's Digital Health Ecosystem: Opportunities and Challenges for Investors
India digital health investment is on the rise. Discover the potential and challenges of investing in India's booming digital healthcare sector. Learn about funding trends, key categories, and success factors for investors.
Defying Expectations: Digital Health Ecosystem in the U.S. Thrives in H1 2024
US digital health booms in H1 2024 with $9.6B funding. Discover key trends, AI impact, and top-funded areas in North America's thriving digital health ecosystem.
Digital Health Funding in Asia Pacific: A H1 2024 Overview
Digital health funding in Asia Pacific took a downturn in H1 2024. Explore the challenges and opportunities in this dynamic market, including a deep dive into online marketplaces, patient solutions, and key players like PharmEasy and TaiDoc Health.
Digital Health Funding H1 2024: Signs of Recovery or False Dawn?
Despite a turbulent 2023, Digital Health Funding in H1 2024 showed surprising resilience with $12.4 billion invested. This resurgence points to renewed investor confidence in AI-driven healthcare solutions.
H1 2024 Digital Health Funding: Reaching the Turning Point
H1 2024 digital health funding demonstrated strong performance, with $12.4 billion invested across 719 deals.
HLTH Europe 2024: Digital Health Ecosystem Pulse Check
Discover the highlights and key takeaways from the inaugural HLTH Europe 2024 Conference in Amsterdam, featuring expert panels, networking events, and groundbreaking discussions on the future of digital health.
The Rise of Big Tech in Healthcare: Opportunities and Challenges
Big Tech in healthcare is rapidly advancing, offering exciting opportunities and challenges around data ownership and safety.
Key Perspectives from Health.Tech 2024
The Health.Tech 2024 conference, brought together the innovators in the DACH digital health sector. Powered by Bits & Pretzels, the conference provided a platform for insightful discussions and forward-thinking strategies in healthcare technology.
Is Big Tech Important to Digital Health Innovation?
Discover how Big Tech is revolutionizing digital health with breakthroughs in data analytics, AI/ML models, and cloud computing. Learn about the key role of companies like Amazon, Google, Microsoft, and Apple in driving innovation and improving healthcare delivery.
Digital Health Exits: Trends, Key Sectors, and Geographical Distribution
Discover the latest trends and insights on digital health exits, including IPOs, SPACs, and M&As. Explore key sectors, geographical distribution, and notable cases in the digital health industry.
Partnerships in Digital Health Reach New Heights in May: Record-breaking 375 Partnerships Announced
Discover the latest trends and insights in the digital health sector as we explore the record-breaking 375 partnerships announced in May 2024. Learn about the geographic distribution, industry representation, and medical focus of these collaborations, and get an overview of the notable partnerships that are shaping the future of healthcare.
Akili Merges with Virtual Therapeutics to Form a Leading Digital Mental Health Company
Akili merges with Virtual Therapeutics in a go-private deal to create a larger, diversified digital mental health company.
Most Impactful Digital Health Early-Stage Investors in the US Reduce Funding Stress for Their Portfolio Ventures
US Early-Stage Investors in Digital Health. Of 3200 investors deploying capital in the United States, General Catalyst is the most impactful.
Digital Health's Most Impactful Early-Stage Investors in Europe
Discover the most impactful European early-stage investors in Digital Health. Investments, focus areas, therapeutic areas.
Asia's Most Impactful Early-Stage Investors in Digital Health
Discover the most impactful early-stage investors in Digital Health in Asia Pacific. Investments, focus areas, therapeutic areas.
Insights from the 10<sup>th</sup> LSX World Congress 2024
Discover the latest in Digital Health innovation at LSX World Congress 2024. Trends, and collaborations, shaping the future of healthcare.
Algorithms to Cure: How Biopharma is Redefining Innovation with AI
Biopharma R&D is transformed through Digital Health Innovations, Artificial Intelligence Integration and Generative AI
Q1 2024 Digital Health Funding: Unpacking Global Trends
Q1 2024 marks a stagnation of the Digital Health funding decline witnessed in 2023. The first quarter recorded $5.1 billion across 347 deals.
United Kingdom: Europe’s #1 Digital Health Ecosystem
Unlocking Insights: Galen Growth unveils the United Kingdom Digital Health dominance in 2023. Dive into data-driven analysis.
Unveiling the most impactful investors in Digital Health
Insights into core investors in Digital Health. Strategies, performance & contributions revealed. Essential for entrepreneurs & stakeholders.
Empowering Healthcare: Insights from ViVE 2024
Insights from ViVE 2024 - a premier event for digital health executives, offering a platform for strategic business engagement. .
The go-to Digital Health conferences in 2024
Explore Go-to Digital Health conferences in 2024 with Galen Growth. Stay ahead, connect, and innovate in the evolving health tech landscape.
Health Systems and Digital Health: Revolutionize Healthcare in the United States
Explore the healthcare revolution: Health Systems drive Digital Health innovations in 2023. Uncover key trends and collaborations.
Asia Pacific Digital Health 2023: Stabilizing Through Partnerships Amid Funding Challenges
Asia Pacific Digital Health 2023 Trends stabilize through strategic partnerships amid funding challenges. Key trends for 2023 and beyond.
Digital Health Trends 2023: Navigating North American Terrain
Explore the 2023 Digital Health Trends in North America with insights on investment shifts, partnerships, and the rise of AI in healthcare. Download now for a deep dive into Digital Health Trends North America 2023.
Unveiling Digital Health Trends Shaping Europe in 2023
Uncover Digital Health Trends in Europe with venture funding, evidence signals, and Europe's leadership in global funding.
AI's Impact on Healthcare: Insights from the 2024 J.P. Morgan Healthcare Conference
The 2024 J.P. Morgan Healthcare Conference is the event for investors, analysts, and industry leaders seeking to unravel the trends shaping the future of health.
Digital Health Funding 2023: An Ecosystem at a Crucial Turning Point
Explore the transformative shifts and challenges in Digital Health funding in our comprehensive review of 2023 and outlook for 2024. Dive into funding dynamics, investor engagement, regulatory trends, and technological advancements shaping the industry's future.
Unveiling Insights from the 2023 Pharmaceutical Digital Health Innovation Index
The 2023 Pharmaceutical Digital Health Innovation Index. Biopharma Partnerships, AI in Pharma, Patient Outcome Data, and Drug Discovery.
Was HLTH 2023 a Turning Point for Digital Health?
Galen Growth participated at HLTH 2023. Here is our takeaway from the largest Digital Health conference that happened in Las Vegas.
Unpacking Digital Health Funding Trends: Q3 2023 Insights
In Q3 2023, Global Digital Health VC investment declined, posing challenges for both organizations and ventures.
Evaluate and Galen Growth Partner to Bring HealthTech Alpha’s Leading Digital Health Data and Insights to Market
Evaluate and Galen Growth announced a commercial partnership to bring HealthTech Alpha to a broader market.
Digital Health Innovation for Cardiovascular Diseases: A Roundtable Discussion
Join industry experts for a roundtable discussion on digital health innovation for cardiovascular diseases. The discussion will cover patient needs, science and technology behind innovative solutions, reimbursement and regulatory challenges, provider engagement and adoption, and outcomes. Whether you're a healthcare professional or investor interested in digital health solutions for cardiovascular diseases, don't miss this engaging session.
Digital Health Innovation in Cardiovascular Diseases: Insights from the Asia Pacific
Join our upcoming webinar to learn about the digital health innovation landscape for cardiovascular diseases in the Asia Pacific. Our experts will share insights from our new research report that covers the global ecosystem of cardio ventures and highlights key growth drivers, challenges, emerging trends, and opportunities.
Digital Health Innovation in Cardiovascular Diseases: Insights from Europe
Join us on June 15, 2023, at 3:00pm (CET) to learn about Europe’s digital health ecosystem for Cardiology ventures. Our analysts will discuss how European ventures are advancing digital innovation for cardiovascular diseases, the solutions they are working on, and how Europe compares to other key regional ecosystems.
European Digital Health's Oncology Ventures: Insights and Opportunities
Join us on May 25, 2023, at 21:00 to learn about Europe's digital health ecosystem for oncology ventures. Our analysts will discuss how European ventures are advancing digital innovation for oncology, the solutions they are working on, and how Europe compares to other key regional ecosystems.
Digital Health in Oncology: Insights from the US
Join us to learn how US Oncology Ventures are advancing digital innovation in Oncology and how they compare to other key regions. We hope you can join us on May 24th at 3pm ET for this exciting event. Register now to secure your spot and receive updates on the latest developments.
Digital Health in Oncology: Asia Pacific Insights
Join our team for a conversation about the Digital Health ecosystem for Oncology in Asia Pacific on May 23, 2023 at 3pm CET (9pm SGT, 9am ET) and learn how ventures from the region are advancing digital innovation for Oncology in the Asia Pacific Oncology Market.
Europe’s Digital Health Funding Strength: Innovating and Competing in 2023
Europe’s Digital Health ecosystem has seen 36% of ventures raise funds in the last 18 months. Join us on May 11, 2023 to learn about its ability to innovate and compete in 2023, including opportunities, challenges, and practical guidelines for entrepreneurs, investors, and healthcare stakeholders.
Digital Health Funding Strength in North America: Trends, Opportunities, and Challenges
Join our experts on May 11, 2023, for insights into digital health funding strength in North America. Learn about opportunities, challenges, and practical guidelines. Register now!
Unleashing the Power of APAC Digital Health: Exploring the Region's Funding Strength
Join us on May 9, 2023, for an insightful event on Digital Health's Funding Strength in the Asia Pacific region. Our expert analysts will explore the current state of the industry and provide valuable insights into funding trends and the ecosystem's ability to innovate and compete. Don't miss this opportunity to gain valuable insights into the future of digital health in Asia Pacific.
Exploring Digital Health in Massachusetts: Insights from Our Analysts
Join us on April 27, 2023, for an exclusive webinar on Digital Health in Massachusetts that explores the third-largest Digital Health ecosystem in the United States after California and New York. Our team of experts will delve into the funding history, top ventures, and how it compares to Digital Health in the rest of the US.
Insurance Digital Health Innovation Index
Join us for the Insurance Digital Health Innovation Index webinar, a world-first that evaluates the Digital Health activities of Insurers.
Europe Digital Health Funding 2022 Half-Year Results
Join the webinar on the Europe Digital Health Funding Webinar featuring the H1 results on September 1 at 2.30 PM CET by Galen Growth.
Asia Pacific Digital Health funding decelerates significantly except for Early Stage ventures which reached a new high
We invite you to join our webinar on the Asia Pacific Digital Health Funding trends on Tuesday, July 28th at 9:00 AM CET, 3:00 PM SGT. In this webinar our Research team will walk you through what is truly happening in Digital Health in the Asia Pacific Digital Health ecosystem
North America Digital Health funding continues to grow except for Late Stage ventures
We invite you to join our webinar on the North America Digital Health Funding trends on Thursday, July 28th at 3:00 PM CET, 9:00 AM ET, 9:00 PM SGT. In this webinar our Research team will walk you through what is truly happening in Digital Health in the North America Digital Health ecosystem
Health Innovation for Pharma Research
Join us on Tuesday, June 28th to learn more about the importance of Digital Health innovation in the pharmaceutical industry. Reserve your calendar now at 3:00 PM CET, 9:00 AM EST, 9:00 PM SGT
Webinar - The Future of Digital Health is Platforms
Join us on the 5th of May and gain first-hand insights into why we believe Digital Health Platforms are the future of Digital Health.
FY 2021 Europe Digital Health Webinar
Get first-hand insights on the European Digital Health ecosystem from our seasoned team of Digital Health experts at our upcoming webinar. We will be covering the key takeaways from the report, plus insights and trends beyond the report to help power your innovation strategies for 2022. Register today.
FY 2021 North America Digital Health Webinar
Telemedicine: A Temporary Fix or a Lasting Solution? Telemedicine solutions have seen a rise in adoption and normalisation since the COVID-19 pandemic. Global funding for Telemedicine ventures across the world grew by 36%, with the United States contributing the most and APAC following close.
FY 2021 APAC Digital Health Webinar
FY2021 APAC Digital Health Review Get first-hand insights on the APAC Digital Health ecosystem from our seasoned team of Digital Health experts at our upcoming webinar. We will be covering the key takeaways from the report, plus insights and trends beyond the report to help power your innovation strategies for 2022. Register today.
Meet the CEO: Yesmom Is Eliminating Barriers to Diagnostic Lab Testing
Meet Peter Macquart-Moulin, Founder & CEO of Yesmom. Learn how the Digital Health startup is eliminating barriers to diagnostic lab testing in women's health.
Meet the CEO: HealthMetrics Is Helping Corporates Optimise Healthcare Expenses
Meet Alvin Yuan, Founder & CEO of HealthMetrics. Learn how the Digital Health startup is helping corporates optimise healthcare expenses.
Meet the CEO: DoryHealth Is Making Medicine Management Smart and Convenient
Meet Stephan Gath, Co-Founder & CEO of DoryHealth (DoryGo). Learn how the Digital Health startup is making medicine management smart and convenient.
Meet the CEO: Peak Medical Is Improving Rehabilitation Compliance With Tech
Meet Hayley Saddington, Founder & CEO of Peak Medical. Learn how the Digital Health startup is improving rehabilitation compliance with tech.
Mental Health: Evolving and Scaling Resilient Mental Healthcare Solutions - The Records - October 20
Telemedicine: A Temporary Fix or a Lasting Solution? Telemedicine solutions have seen a rise in adoption and normalisation since the COVID-19 pandemic. Global funding for Telemedicine ventures across the world grew by 36%, with the United States contributing the most and APAC following close.
Meet the CEO: Safe Space Is Transforming Access to Mental Healthcare Across Asia
Meet Antoinette Patterson, CEO & Co-founder of Safe Space. Learn how the HealthTech startup transforming access to mental health across Asia.
HealthTech Alpha Demo Day
Telemedicine: A Temporary Fix or a Lasting Solution? Telemedicine solutions have seen a rise in adoption and normalisation since the COVID-19 pandemic. Global funding for Telemedicine ventures across the world grew by 36%, with the United States contributing the most and APAC following close.
Remote Patient Monitoring: The Unstoppable Wave of New Care Models - The Records - September 23
Telemedicine: A Temporary Fix or a Lasting Solution? Telemedicine solutions have seen a rise in adoption and normalisation since the COVID-19 pandemic. Global funding for Telemedicine ventures across the world grew by 36%, with the United States contributing the most and APAC following close.
China Digital Health Ecosystem Analysis and Key Trends Webinar
Telemedicine: A Temporary Fix or a Lasting Solution? Telemedicine solutions have seen a rise in adoption and normalisation since the COVID-19 pandemic. Global funding for Telemedicine ventures across the world grew by 36%, with the United States contributing the most and APAC following close.
Meet the CEO: KimboCare’s Path Towards Enabling Quality Care for All
Meet Franck Tiambo, Co-founder of KimboCare. Learn how the HealthTech startup is enabling quality care for all.
Meet the CEO: Oncoshot Is Orchestrating an Ecosystem to Transform Cancer Clinical Trials
Meet Dr Huren Sivaraj, CEO & Co-Founder of Oncoshot. Learn how the Singapore-based HealthTech startup is transforming cancer clinical trials
Meet the CEO: Saathealth Is Optimising AI to Personalise Digital Health Tools
Meet Aakash Ganju and Aditi Hazra-Ganju, Co-Founders of Saathealth. Learn how Saathealth is using AI to personalise digital healthcare.
Discovering the Tech Side of Digital Health Innovations
Discovering the Tech Side of Digital Health Innovations Healthcare is transforming right before our eyes with advances in technologies, including artificial medical intelligence (AMI), federated learning, virtual reality, and vital screening, challenging the status quo.
Clinical Trials in Southeast Asia: The Challenges and Promises
Telemedicine: A Temporary Fix or a Lasting Solution? Telemedicine solutions have seen a rise in adoption and normalisation since the COVID-19 pandemic. Global funding for Telemedicine ventures across the world grew by 36%, with the United States contributing the most and APAC following close.
A World in Crisis: Solving Mental Health
A World in Crisis: Solving Mental Health The World Health Organization said on July 22, 2021, that the mental health impact of the pandemic would be "long-term and far-reaching" and "everyone is affected in one way or another".
Healthcare With Impact
Telemedicine: A Temporary Fix or a Lasting Solution? Telemedicine solutions have seen a rise in adoption and normalisation since the COVID-19 pandemic. Global funding for Telemedicine ventures across the world grew by 36%, with the United States contributing the most and APAC following close. The whole Telemedicine ecosystem seems to be flourishing, yet some believe this to be a knee-jerk reaction.
Digital Health in Insurance: Delivering Consistent Customer Experience and Reducing Inefficiencies
Telemedicine: A Temporary Fix or a Lasting Solution? Telemedicine solutions have seen a rise in adoption and normalisation since the COVID-19 pandemic. Global funding for Telemedicine ventures across the world grew by 36%, with the United States contributing the most and APAC following close. The whole Telemedicine ecosystem seems to be flourishing, yet some believe this to be a knee-jerk reaction. Will Telemedicine be a permanent norm in healthcare? Join us as we track its development and challenges in future transformation in a conversation with leading industry experts.
Health Management Solutions
Telemedicine: A Temporary Fix or a Lasting Solution? Telemedicine solutions have seen a rise in adoption and normalisation since the COVID-19 pandemic. Global funding for Telemedicine ventures across the world grew by 36%, with the United States contributing the most and APAC following close. The whole Telemedicine ecosystem seems to be flourishing, yet some believe this to be a knee-jerk reaction. Will Telemedicine be a permanent norm in healthcare? Join us as we track its development and challenges in future transformation in a conversation with leading industry experts.
When a Small Sample Helps to Discover Breakthroughs
Telemedicine: A Temporary Fix or a Lasting Solution? Telemedicine solutions have seen a rise in adoption and normalisation since the COVID-19 pandemic. Global funding for Telemedicine ventures across the world grew by 36%, with the United States contributing the most and APAC following close. The whole Telemedicine ecosystem seems to be flourishing, yet some believe this to be a knee-jerk reaction. Will Telemedicine be a permanent norm in healthcare?
Tools in the Hands of Patients and Clinicians
Telemedicine: A Temporary Fix or a Lasting Solution? Telemedicine solutions have seen a rise in adoption and normalisation since the COVID-19 pandemic. Global funding for Telemedicine ventures across the world grew by 36%, with the United States contributing the most and APAC following close. The whole Telemedicine ecosystem seems to be flourishing, yet some believe this to be a knee-jerk reaction. Will Telemedicine be a permanent norm in healthcare? Join us as we track its development and challenges in future transformation in a conversation with leading industry experts.
Remote Monitoring: Shaping Tomorrow’s Delivery of Care
Telemedicine: A Temporary Fix or a Lasting Solution? Telemedicine solutions have seen a rise in adoption and normalisation since the COVID-19 pandemic. Global funding for Telemedicine ventures across the world grew by 36%, with the United States contributing the most and APAC following close. The whole Telemedicine ecosystem seems to be flourishing, yet some believe this to be a knee-jerk reaction. Will Telemedicine be a permanent norm in healthcare?
HealthTech Cohort Summit 2021
HealthTech Cohort Summit 2021 The annual HealthTech Cohort Summit is back! Returning with the new batch of digital health ventures from the Galen Growth 2021 HealthTech Cohort, this year’s event is packed with exciting sessions! Get ready to join nine brilliant conversations surrounding the world of digital health, from solutions empowering patients and clinicians
Meet the CEO: Hanai Is Taking Healthcare Education to Rural Women
Meet Shamala Hinrichsen, CEO & Founder of Hanai. Learn how Hanai is taking healthcare education to rural women.
Meet the CEO: Docosan Is Easing Access to Healthcare in Vietnam
Meet Beth Ann Lopez, CEO & Co-Founder of Docosan. Learn how Docosan is easing access to healthcare in Vietnam.
Meet the CEO: The CareVoice Is Helping Health Insurers Digitise Their Business Through Its Open Platform
Meet Jan Velich, Co-Founder & Chief Business Officer of CareVoice. Learn how CareVoice is helping health insurers digitise their business
Meet the CEO: XCLR8 Is Improving Patient Outcomes With Remote Rehabilitation
Meet Lincoln Dacy, CEO & Co-founder of XCLR8. Learn how XCLR8 is improving patient outcomes with remote rehabilitation.
Europe Digital Health Half-Year 2021 Key Trends
Telemedicine: A Temporary Fix or a Lasting Solution? Telemedicine solutions have seen a rise in adoption and normalisation since the COVID-19 pandemic. Global funding for Telemedicine ventures across the world grew by 36%, with the United States contributing the most and APAC following close. The whole Telemedicine ecosystem seems to be flourishing, yet some believe this to be a knee-jerk reaction. Will Telemedicine be a permanent norm in healthcare? Join us as we track its development and challenges in future transformation in a conversation with leading industry experts.
Asia Pacific Digital Health Half-Year 2021 Key Trends
Telemedicine: A Temporary Fix or a Lasting Solution? Telemedicine solutions have seen a rise in adoption and normalisation since the COVID-19 pandemic. Global funding for Telemedicine ventures across the world grew by 36%, with the United States contributing the most and APAC following close.
Digital Oncology: The Future of Cancer Diagnosis and Treatment - The Records - July 21
Telemedicine: A Temporary Fix or a Lasting Solution? Telemedicine solutions have seen a rise in adoption and normalisation since the COVID-19 pandemic. Global funding for Telemedicine ventures across the world grew by 36%, with the United States contributing the most and APAC following close. The whole Telemedicine ecosystem seems to be flourishing, yet some believe this to be a knee-jerk reaction.
Meet the CEO: Radiobotics Is Augmenting Radiology With Technology
Meet Stine Mølgaard Sørensen, COO & Co-founder of Radiobotics. Learn how Radiobotics is augmenting radiology with technology.
Meet the CEO: Predictiv Is Mapping Health Risks From Fingernail Clippings
Meet Dr. Sajung Yun, CEO of Predictiv. Learn how Predictiv has built a technology that can process genomic information from a small fingernail clipping.
Galen Growth HealthTech Deal Factory - June 16
Discover the Next Generation of HealthTech Startups! In collaboration with Novartis Biome and Baker McKenzie, our quarterly Deal Factory Sessions give you access to Early and Growth Stage startups that are changing healthcare. Be a part of the digital health revolution and help support the next generation of innovators.
Galen Growth HealthTech Deal Factory - June 16
Discover the Next Generation of HealthTech Startups! In collaboration with Novartis Biome and Baker McKenzie, our quarterly Deal Factory Sessions give you access to Early and Growth Stage startups that are changing healthcare. Be a part of the digital health revolution and help support the next generation of innovators.
Meet the CEO: Vault Dragon Is on a Mission To Integrate Healthcare in Asia
Meet Cheng-Tse Tseng, Founder & CEO of Vault Dragon. Learn how Vault Dragon is integrating healthcare and HealthTech in Asia.
Telemedicine: A Temporary Fix or a Lasting Solution? - The Records - June 21
Telemedicine: A Temporary Fix or a Lasting Solution? Telemedicine solutions have seen a rise in adoption and normalisation since the COVID-19 pandemic. Global funding for Telemedicine ventures across the world grew by 36%, with the United States contributing the most and APAC following close. The whole Telemedicine ecosystem seems to be flourishing, yet some believe this to be a knee-jerk reaction.
Galen Growth HealthTech Deal Factory – April 14 (Private Event)
Get access to Early and Growth Stage startups that are changing healthcare. Discover the next generation of HealthTech innovators.
Galen Growth's HealthTech Deal Factory – April 7 & 14 (Private Event)
Get access to Early and Growth Stage startups that are changing healthcare. Discover the next generation of HealthTech innovators.
Galen Growth HealthTech Deal Factory – April 14 (Private Event)
Get access to Early and Growth Stage startups that are changing healthcare. Discover the next generation of HealthTech innovators.
We #ChooseToChallenge - International Women's Day
Today, we celebrate women's achievements in digital health and bring attention to the challenges faced by them.
Webinar: Galen Growth Executive Insights: Europe Digital Health FY 2020 Key Trends
Get a deep dive into Galen Growth's go-to-reference for investors, corporates and startups to develop and improve investments and strategies
Webinar: Galen Growth Executive Insights: APAC Digital Health FY 2020 Key Trends
Get a deep dive into Galen Growth's go-to-reference for investors, corporates and startups to develop and improve investments and strategies
Webinar: Galen Growth Executive Insights: U.S.A. Digital Health FY 2020 Key Trends
Get a deep dive into Galen Growth's go-to-reference for investors, corporates and startups to develop and improve investments and strategies
Facing the Kodak Moment. Will Big Tech’s Entry Into Healthcare Make the Multinational Insurance Carriers Obsolete?
It is no longer a case of when Big Tech will enter Health and Insurance, but how fast and to what degree will disruption come. In this article we examine the recent moves by Amazon, Microsoft, Google and Apple, and how new thinking may challenge the multinational insurance carriers.
How startup ecosystem will shape the healthcare system post-COVID-19
Join our experts to discuss the transformation of the healthcare ecosystem and how startups are shaping healthcare post-COVID
Will Insurers Seize a Once in a Lifetime Opportunity for Change, or Retreat Back Into Their Comfort Zones?
Covid is just the latest (though by far the biggest) in a series of wake-up calls for the big insurers. Will they finally deliver on their digital modernisation agenda?
Digital Health Deal Factory
The Digital Health Deal Factory sessions are back. Hear innovative startups pitch their digital health solutions to investors and corporates.
HealthTech Ecosystems Through the Eyes of Startup CEOs | Singapore - Switzerland
Two Swiss-based startup CEOs and two from Singapore explore their HealthTech ecosystems, solutions, and how it has enabled them to succeed.
Webinar: Asia Pacific HealthTech Investment Landscape - Half Year 2020 Report
Hear additional insights not found in the published report to empower you to better operate and strategise your Digital Health solutions in the future.
Building an effective HealthTech CEO Covid-19 survival strategy
CEO tips and tricks | Series | USA: July 1st, 2020, 9 am (SGT) Weathering the COVID-19 storm, HealthTech startups are in the midst of turmoil: can their solut
Galen Growth Digital Health Cohort Summit 2020
The Digital Health Cohort Summit by Galen Growth is the destination to hear and learn from aspiring Digital Health entepreneurs
COVID-19: The Medical Device Industry Engagement with the Digital Health Ecosystem in APAC
June 25th, 2020, 4 pm (SGT) The COVID-19 pandemic has demonstrated the limitations of existing health systems and business models of healthcare verticals from
Galen Growth HealthTech Deal Factory (Private Event)
June 17th 2020, 2 pm to 5 pm (SGT), via Zoom We provide members with physical and virtual access to qualified and strategically aligned early-and-growth stage
Largest Fundraise in SEA in 2020: A Fireside Chat Between Holmusk and Optum Ventures
June 17th 2020, 5 pm (SGT), via Zoom In May 2020, HealthTech startup Holmusk, announced a US$21.5 million funding round led by Optum Ventures (OV) and Health
Building an effective HealthTech CEO Covid-19 survival strategy
CEO tips and tricks | Series | Malaysia: June 3rd, 2020, 4 pm (SGT) Weathering the COVID-19 storm, HealthTech startups are in the midst of turmoil: can their
Building an effective HealthTech CEO Covid-19 survival strategy
CEO tips and tricks | Series | JAPAN: May 27th, 2020, 4 pm (SGT) / 5pm (JST) Weathering the COVID-19 storm, HealthTech startups are in the midst of turmoil: c
Building an effective HealthTech CEO Covid-19 survival strategy
CEO tips and tricks | Series | PAKISTAN: May 20th, 2020, 4 pm (SGT) Weathering the COVID-19 storm, HealthTech startups are in the midst of turmoil: can their
Building an effective HealthTech CEO Covid-19 survival strategy
CEO tips and tricks | Series | INDIA: May 13th, 2020, 4 pm (SGT) Weathering the COVID-19 storm, HealthTech startups are in the midst of turmoil: can their sol
COVID-19 and the Acceleration of Digital Health in APAC
Webinar in Collaboration with L.E.K: May 12th, 2020, 4 pm (SGT) Following our most recent publication with L.E.K, COVID-19 and the Acceleration of Digital Hea
Building an effective HealthTech CEO Covid-19 survival strategy
CEO tips and tricks | Series | SINGAPORE May 6th, 2020, 4 pm (SGT) Weathering the COVID-19 storm, HealthTech startups are in the midst of turmoil: can their s
Building an effective HealthTech Investor Covid-19 survival strategy
Investor tips and tricks : April 30th, 2020, 4 pm (SGT) Weathering the COVID-19 storm, not only HealthTech startups but also investors are in the midst of tur
Building an effective HealthTech CEO Covid-19 survival strategy
Weathering the COVID-19 storm, HealthTech startups are in the midst of turmoil: can their solution be the catalyst of change in the delivery of healthcare when digital health investment in Asia has substantially slowed down?
Building an effective HealthTech CEO Covid-19 survival strategy
Weathering the COVID-19 storm, HealthTech startups are in the midst of turmoil: can their solution be the catalyst of change in the delivery of healthcare?
Galen Growth HealthTech Deal Factory
Our next Deal Factory Session: April 6th, 2020. We provide members with physical and virtual access to qualified and strategically aligned early-and-growth sta
No insights match both filters.